CliffBio
small molecule

GWYN LO

ETHINYL ESTRADIOL; NORELGESTROMIN

Loss of exclusivityJuly 2029FDA regulatory exclusivity expiry
CompanyVIATRIS SPECIALITY LLC

Drug detail

Brand nameGWYN LO
Active ingredientETHINYL ESTRADIOL; NORELGESTROMIN
Strength0.02MG/24HR;0.22MG/24HR
Dosage formSYSTEM
RouteTRANSDERMAL
ModalitySmall molecule
FDA approvalJuly 2026
Marketing statusRX

Regulatory exclusivity

CodeExpires
NPJuly 2029

More from VIATRIS SPECIALITY LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.